The content provided in this video is for informational and educational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell any securities. All views expressed are those of InsightfulValue and are based on publicly available information believed to be reliable, but no guarantee is made as to its accuracy or completeness. Always conduct your own research or consult a licensed financial advisor before making any investment decisions. Investing in the stock market involves risks, including the loss of principal.
Please be aware that the stock prices displayed on this website represent a curated selection of data. On desktop devices, you will see a wider range of stock prices, while on mobile devices, we provide a more streamlined view for better user experience and readability.
Our focus is on assessing a company's overall value and performance, rather than analyzing price fluctuations, even if we do watch prices in order to find companies trading below their intrinsic value. For more detailed charting and comprehensive market analysis, we recommend consulting a professional financial service or utilizing advanced charting tools.
We strive to provide accurate and timely information, but we encourage you to verify any financial data before making investment decisions.
Overview
Kyowa Kirin is a global specialty pharmaceutical company that focuses on research and development, manufacturing, and commercialization of prescription drugs and consumer healthcare products. The company was founded in 1949 in Tokyo, Japan as Kyowa Hakko Kogyo Co., Ltd. and changed its name to Kyowa Kirin Co., Ltd. in 2008. They have a presence in over 30 countries worldwide, with a significant presence in the United States, Europe, and Asia. Kyowa Kirin is known for its focus on rare diseases, oncology, and neuroscience, as well as for its strong research and development capabilities. The company's mission is to contribute to the health and well-being of people around the world through innovative pharmaceutical and healthcare products. Their core values include putting patients first, promoting diversity and inclusion, and being a responsible corporate citizen. Kyowa Kirin has a diverse portfolio of prescription drugs, over-the-counter products, and medical devices. Some of their notable products include the biologic therapies Poteligeo and Crysvita, used to treat rare diseases, and the popular gastrointestinal medicine Nexium. In addition to its pharmaceutical business, Kyowa Kirin also has a consumer healthcare division that offers a range of self-care products, including pain relief patches, digestive health supplements, and cold and flu remedies. The company has a strong commitment to sustainability and corporate responsibility, with initiatives focused on reducing its environmental impact, promoting gender equality and diversity, and supporting local communities through various philanthropic activities. Overall, Kyowa Kirin is a prominent player in the pharmaceutical industry, known for its dedication to improving the lives of patients and for its strong presence in both established and emerging markets.
π InsightfulValue is a platform for public company analysis.
π We provide a database of public companies, with a focus on value investing principles.
π We carefully select every company in our database. With only 1939 listed, there's a reason for that.
π The reason is simple β we only select the best-performing public companies, true champions. And we know exactly what we mean by "champion."
π For us, a champion is a company with strong finances, a history of impressive dividends, great management, and standout products or services. We mean it.
π For each company, we have 465 questions and answers covering every aspect of their market position and operations. Everything.
π ... plus additional 98 Q&A about the industry each company operates in.
InsightfulValue is an independent platform dedicated to value investing research. The information provided on this website is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. We are not financial advisors, investment consultants, or licensed consultants. Our analyses, insights, and criteria are based on principles learned from renowned value investors such as Benjamin Graham, Warren Buffett, and Charlie Munger, but they should not be considered personalized investment recommendations. Investing in financial markets carries risks, and past performance is not indicative of future results. Users of this website should conduct their own due diligence and consult with a qualified professional before making any financial or investment decisions. InsightfulValue assumes no liability for any financial losses or decisions made based on the information provided on this site. By using this website, you acknowledge and accept that all investments involve risk and that InsightfulValue does not guarantee any financial outcomes.